Development of in vivo tumour models for non-invasive proof-of-principle investigation of novel therapeutic agents. Engineering and characterisation of bioluminescent cell reporter systems for in vivo analysis of anti-cancer therapy pharmacodynamics.
Despite significant advances in cancer treatment, clinical response remains suboptimal and there is a continued requirement for improved chemotherapeutics. The attrition rate for new therapies is high, due principally to lack of in vivo efficacy and poor pharmacodynamics. Consequently better systems...
Main Author: | |
---|---|
Other Authors: | |
Language: | en |
Published: |
University of Bradford
2012
|
Subjects: | |
Online Access: | http://hdl.handle.net/10454/5391 |